DRUG MARKETING Off-label marketing: free speech or illegal promotion?

被引：1
|
作者：
Silverman, Ed [1 ]
机构：
[1] Pharmalot, Millburn, NJ USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
关键词：
D O I：
10.1136/bmj.f320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [21] FRAUD Abbott Labs to pay $1.5 billion to resolve charges of off-label drug marketing
    Reisch, Marc
    [J]. CHEMICAL & ENGINEERING NEWS, 2012, 90 (20) : 9 - 9
  • [22] Prohibition against off-label drug promotion challenged
    Woodward, Cal
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (05) : 518 - 518
  • [23] Manufacturers' promotion of off-label drug use: implications for drug safety
    Zieve, Allison
    Carome, Michael A.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2016, 15 (09) : 1149 - 1151
  • [24] Lawsuit challenges FDA's authority to prevent off-label marketing
    Dyer, Owen
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [25] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
  • [26] Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Studdert, David M.
    [J]. PLOS MEDICINE, 2011, 8 (04) : 13
  • [27] Marketing off-label uses to physicians: FDA's draft (mis)guidance
    Gass, Andy
    Wilson, Jennifer
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2008, 8 (03): : 1 - 3
  • [28] FDA is criticised for poor oversight of drug companies' promotion of off-label drug use
    Tanne, Janice Hopkins
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7665):
  • [29] The next forum for unraveling FDA off-label marketing rules: State and federal legislatures
    Sinha, Michael S.
    Kesselheim, Aaron S.
    [J]. PLOS MEDICINE, 2018, 15 (05):
  • [30] Off-label drug in the newborn
    Cuzzolin, Laura
    [J]. JOURNAL OF PEDIATRIC AND NEONATAL INDIVIDUALIZED MEDICINE, 2014, 3 (02):
12345